M28804
2-(2-Methylaminoethyl)pyridine
97%
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule empirique (notation de Hill) :
C8H12N2
Numéro CAS:
Poids moléculaire :
136.19
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
227-086-4
MDL number:
Assay:
97%
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderQuality Level
assay
97%
refractive index
n20/D 1.518 (lit.)
bp
113-114 °C/30 mmHg (lit.)
density
0.984 g/mL at 25 °C (lit.)
SMILES string
CNCCc1ccccn1
InChI
1S/C8H12N2/c1-9-7-5-8-4-2-3-6-10-8/h2-4,6,9H,5,7H2,1H3
InChI key
UUQMNUMQCIQDMZ-UHFFFAOYSA-N
Gene Information
human ... HRH1(3269), HRH3(11255)
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Classe de stockage
10 - Combustible liquids
wgk
WGK 2
flash_point_f
206.6 °F - closed cup
flash_point_c
97 °C - closed cup
ppe
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Mattis Bertlich et al.
Life sciences, 187, 17-21 (2017-08-19)
Betahistine is a histamine analogue that is used for the treatment of Menière's disease. Animal studies showed that it increases local blood flow in the stria vascularis. In terms of its mode of action, recent studies have prompted discussion of
Hiroshi Ueno et al.
The Libyan journal of medicine, 15(1), 1808361-1808361 (2020-08-19)
The administration of therapeutic agents is difficult in many patients, such as patients with post-operative delirium or dementia or patients with schizophrenia, who are upset in an emergency room. Therefore, the development of a new method for administering therapeutic agents
Brahim Tighilet et al.
Frontiers in neurology, 9, 431-431 (2018-06-27)
This study is a pharmacokinetic (PK) and pharmacodynamics (PD) approach using betahistine doses levels in unilateral vestibular neurectomized cats (UVN) comparable to those used in humans for treating patients with Menière's disease. The aim is to investigate for the first